Clinical Trial Update: Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

View source ↗

Summary

A clinical trial update exploring the use of circulating tumor DNA (ctDNA) to detect melanoma recurrence earlier than current methods.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: University of Utah | Conditions: Melanoma | Status: ACTIVE_NOT_RECRUITING